N. SOYER Et Al. , "Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis," AHOS , 2017
SOYER, N. Et Al. 2017. Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis. AHOS .
SOYER, N., TURGUT, M., HAZNEDAROĞLU, İ. C., yılmaz, f., AYDOĞDU, İ., PİR, A., ... Karakuş, V.(2017). Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis . AHOS
SOYER, NUR Et Al. "Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis," AHOS, 2017
SOYER, NUR Et Al. "Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis." AHOS , 2017
SOYER, N. Et Al. (2017) . "Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis." AHOS .
@conferencepaper{conferencepaper, author={NUR SOYER Et Al. }, title={Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis}, congress name={AHOS}, city={}, country={}, year={2017}}